Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Rowland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Drug Discovery & Development|August 29, 2002
Using X-ray crystallography in drug discoveryR Scott Rowland
Frontiers in Neuroscience|February 23, 2024
Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMAJennifer Warner-Schmidt, Martin Stogniew, Blake Mandell, et al.
Journal of Medicinal Chemistry|August 23, 2013
Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoformChristopher Blackburn, Cynthia Barrett, Janice Chin, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoformChristopher Blackburn, Cynthia Barrett, Mable Brunson, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitorsAlexandra E Gould, Ruth Adams, Sharmila Adhikari, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|August 29, 2002
Using X-ray crystallography in drug discoveryR Scott Rowland
Frontiers in Neuroscience|February 23, 2024
Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMAJennifer Warner-Schmidt, Martin Stogniew, Blake Mandell, et al.
Journal of Medicinal Chemistry|August 23, 2013
Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoformChristopher Blackburn, Cynthia Barrett, Janice Chin, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoformChristopher Blackburn, Cynthia Barrett, Mable Brunson, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitorsAlexandra E Gould, Ruth Adams, Sharmila Adhikari, et al.
Pageof 1